Sensient Technologies Corporation
SXT
NYSE·Basic Materials·Chemicals - Specialty·Mkt cap $5.7B
$134.84
▼ -1.07%
P/E
36.15
Mkt Cap
$5.7B
52-Wk Range
$82.60–$138.82
52-Week Range
$82.60 - $138.82
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 19.1% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- 140+ year heritage and established relationships with major global food, beverage, and pharmaceutical manufacturers
- Vertically integrated operations with proprietary manufacturing processes and technical expertise in color and flavor chemistry
- Diversified product portfolio and global distribution network reducing customer concentration risk and enabling cross-selling opportunities
- Strong R&D capabilities and innovation pipeline supporting development of natural, clean-label, and specialty ingredient solutions
Bear Case
2 risks
- Low volatility (beta 0.8).
- Significant premium - growth priced in
Growth
Stable outlook
Rising consumer demand for natural colors and flavors driven by clean-label and health-conscious trends
Value
Significant premium - growth priced in
Momentum
Strong
+19.5% over 3m
Quality
Stable
Strong fundamentals
Dividend
Modest
1.22% yield
Smart-money signal
Who's buying SXT right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 30, 2026
JUL 24, 2026
Reported EPS of $1.20 vs $1.03 consensus (+16.5% surprise). Revenue of $462.1M vs $448.8M expected (+3.0%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+16.5%
Revenue trend · last 8Q
—
+8%
+2%
+3%
+5%
+5%
+11%
+12%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$392.6M
$376.4M
$392.3M
$414.2M
$412.1M
$393.4M
$435.8M
$462.1M
Margins · last 8Q
Gross
37.4%
Operating
16.6%
Profit
11.1%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: UBS · Jun 22, 2026
vs Industry
How SXT stacks vs Chemicals - Specialty
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related